NEW YORK, Oct. 18, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Asia-Pacific Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery

http://www.reportlinker.com/p0739467/Asia-Pacific-Diabetes-Care-Devices-...

Asia-Pacific Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery

Summary

GlobalData's new report, "Asia-Pacific Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery" provides key market data on the Asia-Pacific Diabetes Care Devices market – Australia, China, India and Japan. The report provides value (USD million) data for all the market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Countries covered include Australia, China, India and Japan.

- Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.

- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the market categories and countries.

- Global corporate-level profiles of key companies operating within the Asia-Pacific Diabetes Care Devices market..

- Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Novo Nordisk A/S, Arkray, Inc., Eli Lilly and Company, Abbott Laboratories and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Asia-Pacific Diabetes Care Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 7

2 Introduction 9

2.1 What is This Report About? 9

3 Diabetes Care Devices in Asia-Pacific 10

3.1 Diabetes Care Devices Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 10

3.2 Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, 2004-2018 11

3.3 Diabetes Care Devices, Asia-Pacific, Company share (2010-2011) 16

4 Diabetes Care Devices In Japan 18

4.1 Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, 2004-2018 18

4.2 Diabetes Care Devices, Japan, Distribution Share (2010-2011) 23

4.2.1 Glucose Monitoring, Japan, Distribution Share (2010-2011) 23

4.2.2 Insulin Delivery, Japan, Distribution Share (2010-2011) 23

4.3 Diabetes Care Devices, Japan, Company Share (2010-2011) 24

4.3.1 Diabetes Care Devices, Japan, Company Share (2010-2011) 24

4.3.2 Glucose Monitoring, Japan, Company Share (2010-2011) 26

4.3.3 Insulin Delivery, Japan, Company Share (2010-2011) 28

5 Diabetes Care Devices In Australia 30

5.1 Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018 30

5.2 Diabetes Care Devices, Australia, Distribution Share (2010-2011) 35

5.2.1 Glucose Monitoring, Australia, Distribution Share (2010-2011) 35

5.2.2 Insulin Delivery, Australia, Distribution Share (2010-2011) 35

5.3 Diabetes Care Devices, Australia, Company Share (2010-2011) 36

5.3.1 Diabetes Care Devices, Australia, Company Share (2010-2011) 36

5.3.2 Glucose Monitoring, Australia, Company Share (2010-2011) 38

5.3.3 Insulin Delivery, Australia, Company Share (2010-2011) 40

6 Diabetes Care Devices In China 42

6.1 Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, 2004-2018 42

6.2 Diabetes Care Devices, China, Distribution Share (2010-2011) 47

6.2.1 Glucose Monitoring, China, Distribution Share (2010-2011) 47

6.2.2 Insulin Delivery, China, Distribution Share (2010-2011) 47

6.3 Diabetes Care Devices, China, Company Share (2010-2011) 48

6.3.1 Diabetes Care Devices, China, Company Share (2010-2011) 48

6.3.2 Glucose Monitoring, China, Company Share (2010-2011) 50

6.3.3 Insulin Delivery, China, Company Share (2010-2011) 52

7 Diabetes Care Devices In India 54

7.1 Diabetes Care Devices, India, Overall Revenue ($m), USD Constant, 2004-2018 54

7.2 Diabetes Care Devices, India, Distribution Share (2010-2011) 59

7.2.1 Glucose Monitoring, India, Distribution Share (2010-2011) 59

7.2.2 Insulin Delivery, India, Distribution Share (2010-2011) 59

7.3 Diabetes Care Devices, India, Company Share (2010-2011) 60

7.3.1 Diabetes Care Devices, India, Company Share (2010-2011) 60

7.3.2 Glucose Monitoring, India, Company Share (2010-2011) 62

7.3.3 Insulin Delivery, India, Company Share (2010-2011) 64

8 Overview of Key Companies in Asia-Pacific Diabetes Care Devices Market 66

8.1 F. Hoffmann-La Roche Ltd. 66

8.1.1 Company Overview 66

8.1.2 Share in the Asia-Pacific Diabetes Care Devices Market 66

8.2 LifeScan, Inc. 67

8.2.1 Company Overview 67

8.2.2 Share in the Asia-Pacific Diabetes Care Devices Market 67

8.3 Novo Nordisk A/S 68

8.3.1 Company Overview 68

8.3.2 Share in the Asia-Pacific Diabetes Care Devices Market 68

8.4 ARKRAY, Inc. 69

8.4.1 Company Overview 69

8.4.2 Share in the Asia-Pacific Diabetes Care Devices Market 69

8.5 Eli Lilly and Company 70

8.5.1 Company Overview 70

8.5.2 Share in the Asia-Pacific Diabetes Care Devices Market 70

8.6 Abbott Laboratories 71

8.6.1 Company Overview 71

8.6.2 Share in the Asia-Pacific Diabetes Care Devices Market 71

8.7 Sanofi 72

8.7.1 Company Overview 72

8.8 Medtronic, Inc. 72

8.8.1 Company Overview 72

8.9 Bayer HealthCare AG 73

8.9.1 Company Overview 73

8.10 Terumo Corporation 73

8.10.1 Company Overview 73

8.11 Becton, Dickinson and Company 74

8.11.1 Company Overview 74

8.12 Nipro Corporation 74

8.12.1 Company Overview 74

8.13 Hindustan Syringes & Medical Devices Ltd. 75

8.13.1 Company Overview 75

8.14 Animas Corporation 75

8.14.1 Company Overview 75

8.15 B. Braun Melsungen AG 75

8.15.1 Company Overview 75

9 Diabetes Care Devices Market Pipeline Products 76

10 Financial Deals Landscape 79

10.1 Partnerships 79

10.1.1 Bioton And SciGen Amend Distribution Agreement With Bayer HealthCare 79

10.1.2 Insulet Expands Distribution Agreement With Ypsomed Holding 81

11 Recent Developments 82

11.1 Strategy And Business Planning 82

11.1.1 Aug 28, 2012: Medtronic Opens Shanghai Innovation Center 82

11.1.2 Aug 09, 2012: Takeda Establishes Development Center In China 82

11.1.3 Apr 06, 2012: Biocon Opens New INR2 Billion Biologics Research Facility In Bangalore, India 83

11.1.4 Mar 27, 2012: Terumo Establishes New Holding Company In Singapore 83

11.1.5 Nov 04, 2011: Takeda Announces New Structure Of Business Operations 84

11.2 Research And Development 85

11.2.1 Jul 17, 2012: Greatbatch To Establish R&D Centre In Singapore 85

11.2.2 Apr 04, 2012: Takeda Joins Structural Genomics Consortium To Fund Collective Drug Research 86

11.2.3 Mar 27, 2012: Bayer HealthCare And Tsinghua University Extend Innovative Drug Discovery Partnership 87

11.3 Legal and Regulatory 88

11.3.1 Aug 01, 2012: Terumo Files Lawsuit For Compensation Of Damages Against Olympus 88

11.3.2 Jun 29, 2012: Sucampo Pharma Provides Update On Anticipated Arbitration Decision 88

11.3.3 May 30, 2012: Sucampo Announces Change In Date Of Anticipated Arbitration Decision In Dispute With Takeda 88

11.3.4 Apr 17, 2012: Sanmina-SCI Suzhou, China Facility Receives ISO 13485 Certification For Medical Devices 89

12 Appendix 90

12.1 Definitions of Markets Covered in the Report 91

12.1.1 Diabetes Care Devices 91

12.2 Research Methodology 92

12.3 Secondary Research 92

12.4 Primary Research 93

12.5 Models 93

12.6 Forecasts 94

12.7 Expert Panels 94

12.8 GlobalData Consulting 94

12.9 Currency Conversion 95

12.10 Contact Us 95

12.11 Disclaimer 95

1.1 List of Tables

Table 1: Diabetes Care Devices, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018 10

Table 2: Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, 2004-2018 11

Table 3: Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, Historic, 2004-2011 13

Table 4: Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 15

Table 5: Diabetes Care Devices, Asia-Pacific, Company share by Revenue ($m), USD Constant, 2010-2011 17

Table 6: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, 2004-2018 18

Table 7: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, Historic, 2004-2011 20

Table 8: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 22

Table 9: Glucose Monitoring, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011 23

Table 10: Insulin Delivery, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011 23

Table 11: Diabetes Care Devices, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011 25

Table 12: Glucose Monitoring, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011 27

Table 13: Insulin Delivery, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011 29

Table 14: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018 30

Table 15: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, Historic, 2004-2011 32

Table 16: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 34

Table 17: Glucose Monitoring, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011 35

Table 18: Insulin Delivery, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011 35

Table 19: Diabetes Care Devices, Australia, Company Share, USD Constant, (2010-2011) 37

Table 20: Glucose Monitoring, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011 39

Table 21: Insulin Delivery, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011 41

Table 22: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, 2004-2018 42

Table 23: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 44

Table 24: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 46

Table 25: Glucose Monitoring, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011 47

Table 26: Insulin Delivery, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011 47

Table 27: Diabetes Care Devices, China, Company Share, USD Constant, (2010-2011) 49

Table 28: Glucose Monitoring, China, Company Share by Revenue ($m), USD Constant, 2010-2011 51

Table 29: Insulin Delivery, China, Company Share by Revenue ($m), USD Constant, 2010-2011 53

Table 30: Diabetes Care Devices, India, Overall Revenue ($m), USD Constant, 2004-2018 54

Table 31: Diabetes Care Devices, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 56

Table 32: Diabetes Care Devices, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 58

Table 33: Glucose Monitoring, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 59

Table 34: Insulin Delivery, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 59

Table 35: Diabetes Care Devices, India, Company Share, USD Constant, (2010-2011) 61

Table 36: Glucose Monitoring, India, Company Share by Revenue ($m), USD Constant, 2010-2011 63

Table 37: Insulin Delivery, India, Company Share by Revenue ($m), USD Constant, 2010-2011 65

Table 38: Diabetes Care Devices Market Pipeline Products 76

Table 39: Bioton And SciGen Amend Distribution Agreement With Bayer HealthCare 79

Table 40: Insulet Expands Distribution Agreement With Ypsomed Holding 81

1.2 List of Figures

Figure 1: Diabetes Care Devices, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 10

Figure 2: Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, 2004-2018 11

Figure 3: Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, Historic, 2004-2011 12

Figure 4: Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 14

Figure 5: Diabetes Care Devices, Asia-Pacific, Company share (%), 2011 16

Figure 6: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, 2004-2018 18

Figure 7: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, Historic, 2004-2011 19

Figure 8: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 21

Figure 9: Diabetes Care Devices, Japan, Company Share (%), 2011 24

Figure 10: Glucose Monitoring, Japan, Company Share (%), 2011 26

Figure 11: Insulin Delivery, Japan, Company Share (%), 2011 28

Figure 12: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018 30

Figure 13: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, Historic, 2004-2011 31

Figure 14: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 33

Figure 15: Diabetes Care Devices, Australia, Company Share (%), 2011 36

Figure 16: Glucose Monitoring, Australia, Company Share (%), 2011 38

Figure 17: Insulin Delivery, Australia, Company Share (%), 2011 40

Figure 18: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, 2004-2018 42

Figure 19: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 43

Figure 20: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 45

Figure 21: Diabetes Care Devices, China, Company Share (%), 2011 48

Figure 22: Glucose Monitoring, China, Company Share (%), 2011 50

Figure 23: Insulin Delivery, China, Company Share (%), 2011 52

Figure 24: Diabetes Care Devices, India, Overall Revenue ($m), USD Constant, 2004-2018 54

Figure 25: Diabetes Care Devices, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 55

Figure 26: Diabetes Care Devices, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 57

Figure 27: Diabetes Care Devices, India, Company Share (%), 2011 60

Figure 28: Glucose Monitoring, India, Company Share (%), 2011 62

Figure 29: Insulin Delivery, India, Company Share (%), 2011 64

Figure 30: F. Hoffmann-La Roche Ltd., Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2011 66

Figure 31: LifeScan, Inc., Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2011 67

Figure 32: Novo Nordisk A/S, Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2011 68

Figure 33: ARKRAY, Inc., Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2011 69

Figure 34: Eli Lilly and Company, Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2011 70

Figure 35: Abbott Laboratories, Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2011 71

Companies mentioned

F. Hoffmann-La Roche Ltd.

LifeScan, Inc.

Novo Nordisk A/S

ARKRAY, Inc.

Eli Lilly and Company

Abbott Laboratories

Sanofi

Medtronic, Inc.

Bayer HealthCare AG

Terumo Corporation

Becton, Dickinson and Company

Nipro Corporation

Hindustan Syringes & M

To order this report:

Pathology Industry: Asia-Pacific Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery

Contact Nicolas: nicolasbombourg@reportlinker.com
US: (805)-652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker